Synchrony Pharma

Stevenage, United Kingdom Founded: 2008 • Age: 18 yrs Acquired By CNX Therapeutics
Generic drugs are manufactured by Synchrony Pharma in the UK.

About Synchrony Pharma

Synchrony Pharma is a Healthcare company based in Stevenage (United Kingdom) founded in 2008, and was acquired by CNX Therapeutics in July 2022. Generic drugs are manufactured by Synchrony Pharma in the UK. Its focus areas include Traditional Pharmaceuticals.

Company details

Synchrony Pharma was established in 2008 and is based in Stevenage, United Kingdom. Operations are centered on the production of generic pharmaceuticals within the healthcare sector. Affordable equivalents to branded medications are developed and supplied to support global access to essential treatments. Focus is placed on regulatory compliance and efficient manufacturing processes to meet market demands in various therapeutic areas.

  • Headquarters Stevenage, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website synchronypharma.com
  • Social LinkedIn
  • Acquired by CNX Therapeutics (Jul 2022)
Key Metrics

Investors in Synchrony Pharma

Synchrony Pharma has secured backing from 1 investor. Prominent investors backing the company include CNX Therapeutics.

All
InvestorDescriptionFounded YearDomainLocation
Distributor of specialty drugs
2021cnx-therapeutics.comLondon, United Kingdom
Premium access

Investor details for Synchrony Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Synchrony Pharma

2 dated milestones of Synchrony Pharma across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Synchrony Pharma is founded.
  2. Exit Acquired by CNX Therapeutics.

Web traffic of Synchrony Pharma

Websites that share an audience with Synchrony Pharma (synchronypharma.com).

Similar websites

Websites whose visitors overlap most with Synchrony Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
facebook.com
100%
12.1B#3View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Synchrony Pharma

Synchrony Pharma was founded in 2008.

Synchrony Pharma is headquartered in Stevenage, United Kingdom. It is registered at Stevenage, Hertfordshire, United Kingdom.

Synchrony Pharma was established in 2008 and is based in Stevenage, United Kingdom. Operations are centered on the production of generic pharmaceuticals within the healthcare sector. Affordable equivalents to branded medications are developed and supplied to support global access to essential treatments. Focus is placed on regulatory compliance and efficient manufacturing processes to meet market demands in various therapeutic areas.

Synchrony Pharma has 1 investor. Key investors include CNX Therapeutics.

Yes. Synchrony Pharma was acquired by CNX Therapeutics in July 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available